Skip to content
Oncology Research Hub

Pennsylvania

Cancer clinical trials in Pennsylvania

503 cancer studies are recruiting participants at sites in 87 cities across Pennsylvania as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse Pennsylvania by city

Cities with the most studies recruiting right now.

Every Pennsylvania city with a recruiting study

By research area: Lung Cancer (144), Breast Cancer (121), Lymphoma (105), Prostate Cancer (58), Melanoma (42), Pancreatic Cancer (33).

Philadelphia (296), Pittsburgh (217), Hershey (50), York (39), Danville (37), Allentown (36), Wilkes-Barre (30), Bethlehem (29), Monroeville (23), Erie (22), Lewisburg (22), Sayre (22), Lancaster (21), Hazleton (19), Dickson City (18), Chambersburg (17), Ephrata (17), Lebanon (17), West Reading (17), Wynnewood (17), East Stroudsburg (16), Gettysburg (16), Greensburg (16), Mechanicsburg (16), Harrisburg (15), Media (15), Willow Grove (15), Scranton (14), Chadds Ford (13), Paoli (12), Bryn Mawr (11), Farrell (10), New Castle (10), Beaver (9), Carlisle (9), Cranberry Township (9), Easton (9), Indiana (9), Johnstown (9), Natrona Heights (9), Pottsville (9), Seneca (9), Washington (9), Bala-Cynwyd (8), Jefferson Hills (8), N. Huntingdon (8), Wexford (8), Williamsport (8), Hanover (7), West Mifflin (7), Butler (6), Horsham (6), Moon Township (6), Phoenixville (6), Uniontown (6), Altoona (5), Broomall (5), East Norriton (5), McKeesport (5), Meadville (5), Mount Pleasant (5), Meadowbrook (4), Quakertown (4), Doylestown (3), Reading (3), Sellersville (3), Stroudsburg (3), Bensalem (2), DuBois (2), Fountain Hill (2), Furlong (2), Pottstown (2), State College (2), West Chester (2), Abington (1), Bethel Park (1), Darby (1), Dunmore (1), Langhorne (1), Newton (1), North Huntingdon (1), Philadephia (1), Phildelphia (1), Philidelphia (1), Selinsgrove (1), Wellsboro (1), Wyomissing (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Pennsylvania

Basic details from each study's public record (the 12 most recently updated of 503). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Recruiting in
    Hershey
    Registry record
    NCT06324357 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Pennsylvania on ClinicalTrials.gov.

Lung cancer: recently updated in Pennsylvania

  1. JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Texas Southwestern Medical Center
    Recruiting in
    Pittsburgh
    Registry record
    NCT02468024 · updated
  2. LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    NovoCure GmbH
    Recruiting in
    Philadelphia · Pittsburgh
    Registry record
    NCT06216301 · updated
  3. Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Pittsburgh
    Registry record
    NCT06287775 · updated
  4. A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Recruiting in
    Philadelphia
    Registry record
    NCT07277413 · updated
  5. A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Philadelphia
    Registry record
    NCT07513376 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Pennsylvania on ClinicalTrials.gov.

Prostate cancer: recently updated in Pennsylvania

  1. Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Philadelphia
    Registry record
    NCT04038502 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Pennsylvania on ClinicalTrials.gov.

Melanoma: recently updated in Pennsylvania

  1. Sulforaphane for the Prevention of Melanoma in Patients With Multiple Atypical Nevi and a Prior History of Melanoma

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Pittsburgh
    Registry record
    NCT07040280 · updated
  2. Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

    • Phase 3
    • Ages 75 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Chadds Ford · East Norriton · Erie · and 3 more U.S. locations
    Registry record
    NCT07068074 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Pennsylvania on ClinicalTrials.gov.

Lymphoma: recently updated in Pennsylvania

  1. Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eastern Cooperative Oncology Group
    Recruiting in
    Chadds Ford · Danville · Wilkes-Barre
    Registry record
    NCT06724237 · updated
  2. A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Nurix Therapeutics, Inc.
    Recruiting in
    Pittsburgh
    Registry record
    NCT07221500 · updated
  3. ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Newave Pharmaceutical Inc
    Recruiting in
    Pittsburgh
    Registry record
    NCT07342478 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Pennsylvania on ClinicalTrials.gov.

Ask about studies in Pennsylvania

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call